158 related articles for article (PubMed ID: 38004080)
1. Genetic Variants in Matrix Metalloproteinases
Nehring P; Gromadzka G; Jastrzębski M; Przybyłkowski A
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004080
[No Abstract] [Full Text] [Related]
2. rs3918242 MMP9 gene polymorphism is associated with myocardial infarction in Mexican patients.
Rodríguez-Pérez JM; Vargas-Alarcón G; Posadas-Sánchez R; Zagal-Jiménez TX; Ortíz-Alarcón R; Valente-Acosta B; Tovilla-Zárate C; Nostroza-Hernández C; Pérez-Méndez O; Pérez-Hernández N
Genet Mol Res; 2016 Mar; 15(1):15017776. PubMed ID: 26985929
[TBL] [Abstract][Full Text] [Related]
3. Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke.
Hao Y; Tian S; Sun M; Zhu Y; Nie Z; Yang S
Int J Clin Exp Pathol; 2015; 8(9):11647-52. PubMed ID: 26617904
[TBL] [Abstract][Full Text] [Related]
4. Associations between matrix metalloproteinase gene polymorphisms and the development of cerebral infarction.
Zhao JH; Xu YM; Xing HX; Su LL; Tao SB; Tian XJ; Yan HQ; Ji SB
Genet Mol Res; 2016 Jan; 14(4):19418-24. PubMed ID: 26782596
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis.
Rech TF; Moraes SB; Bredemeier M; de Paoli J; Brenol JC; Xavier RM; Chies JA; Simon D
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002595
[TBL] [Abstract][Full Text] [Related]
6. Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population.
Hu W; Ye Y; Yin Y; Sang P; Li L; Wang J; Wan W; Li R; Bai X; Xie Y; Meng Z
BMC Med Genet; 2018 Feb; 19(1):27. PubMed ID: 29458338
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Pleskovič A; Letonja MŠ; Vujkovac AC; Starčević JN; Caprnda M; Curilla E; Mozos I; Kruzliak P; Prosecky R; Petrovič D
Vasa; 2017 Aug; 46(5):363-369. PubMed ID: 28521653
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
Zhang L; Xi RX; Zhang XZ
Genet Mol Res; 2015 May; 14(2):4616-24. PubMed ID: 25966235
[TBL] [Abstract][Full Text] [Related]
9. Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.
Xu X; Wang L; Xu C; Zhang P; Yong F; Liu H; Wang J; Shi Y
Coron Artery Dis; 2013 Jun; 24(4):259-65. PubMed ID: 23377317
[TBL] [Abstract][Full Text] [Related]
10. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
12. Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients.
Ramezani S; Ezzatifar F; Hojjatipour T; Hemmatzadeh M; Shabgah AG; Navashenaq JG; Aslani S; Shomali N; Arabi M; Babaie F; Jadidi-Niaragh F; Hosseinzadeh R; Feizisani F; Khodayar S; Safari R; Mohammadi H
Mol Biol Rep; 2023 Jan; 50(1):173-183. PubMed ID: 36319784
[TBL] [Abstract][Full Text] [Related]
13. Association of matrix metalloproteinase gene polymorphism with temporomandibular joint degeneration.
Planello AC; Campos MI; Meloto CB; Secolin R; Rizatti-Barbosa CM; Line SR; de Souza AP
Eur J Oral Sci; 2011 Feb; 119(1):1-6. PubMed ID: 21244504
[TBL] [Abstract][Full Text] [Related]
14. Impact of
Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Reznakova V; Kralova M; Hromadka T; Shawkatova I
Mediators Inflamm; 2021; 2021():5573642. PubMed ID: 33986628
[TBL] [Abstract][Full Text] [Related]
15. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.
Guan X; Wang X; Luo H; Wu J; Zhang X; Wu J
Med Sci Monit; 2014 Nov; 20():2269-74. PubMed ID: 25391977
[TBL] [Abstract][Full Text] [Related]
17. Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma.
Markiewicz L; Majsterek I; Przybylowska K; Dziki L; Waszczyk M; Gacek M; Kaminska A; Szaflik J; Szaflik JP
Acta Ophthalmol; 2013 Nov; 91(7):e516-23. PubMed ID: 23800300
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix remodeling genes polymorphisms and risk of chronic bronchitis and recurrent pneumonia in children.
Korytina GF; Akhmadishina LZ; Viktorova EV; Tselousova OS; Danilko KV; Kochetova OV; Viktorova TV
J Hum Genet; 2013 Jul; 58(7):467-74. PubMed ID: 23575435
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in MMP 2, 3 and 9 genes and the susceptibility of osteosarcoma in a Chinese Han population.
Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
Biomarkers; 2016; 21(2):160-3. PubMed ID: 26754027
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
